|
[1]
|
Siegel, R.L., Miller, K.D. and Jemal, A. (2016) Cancer Statistics, 2016. CA: A Cancer Journal for Clinicians, 66, 7-30. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Torre, L.A., Sauer, A.M.G., Chen, M.S., Kagawa‐Singer, M., Jemal, A. and Siegel, R.L. (2016) Cancer Statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016: Converging Incidence in Males and Females. CA: A Cancer Journal for Clinicians, 66, 182-202. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Vanguri, R.S., Fenn, K.M., Kearney, M.R., Wang, Q., Guo, H., Marks, D.K., et al. (2022) Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer. Clinical Breast Cancer, 22, 538-546. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Bhat-Nakshatri, P., Gao, H., Sheng, L., McGuire, P.C., Xuei, X., Wan, J., et al. (2021) A Single-Cell Atlas of the Healthy Breast Tissues Reveals Clinically Relevant Clusters of Breast Epithelial Cells. Cell Reports Medicine, 2, Article 100219. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Viscido, G., Gambardella, G. and di Bernardo, D. (2021) Abstract 214: The Breast Single-Cell Atlas: Single-Cell Transcriptomics for Personalised Medicine. Cancer Research, 81, 214-214. [Google Scholar] [CrossRef]
|
|
[7]
|
Fernández-Nogueira, P., Mancino, M., Fuster, G., López-Plana, A., Jauregui, P., Almendro, V., et al. (2020) Tumor-Associated Fibroblasts Promote Her2-Targeted Therapy Resistance through FGFR2 Activation. Clinical Cancer Research, 26, 1432-1448. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Liu, Y., Fang, Y., Bao, L., Wu, F., Wang, S. and Hao, S. (2022) Intercellular Communication Reveals Therapeutic Potential of Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer. Biomolecules, 12, Article 1478. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Criscitiello, C., Vingiani, A., Maisonneuve, P., Viale, G., Viale, G. and Curigliano, G. (2020) Tumor-Infiltrating Lymphocytes (TILs) in ER+/HER2− Breast Cancer. Breast Cancer Research and Treatment, 183, 347-354. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
DeNardo, D.G. and Ruffell, B. (2019) Macrophages as Regulators of Tumour Immunity and Immunotherapy. Nature Reviews Immunology, 19, 369-382. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Qian, B. and Pollard, J.W. (2010) Macrophage Diversity Enhances Tumor Progression and Metastasis. Cell, 141, 39-51. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Gabrilovich, D.I., Ostrand-Rosenberg, S. and Bronte, V. (2012) Coordinated Regulation of Myeloid Cells by Tumours. Nature Reviews Immunology, 12, 253-268. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Baselga, J. and Swain, S.M. (2009) Novel Anticancer Targets: Revisiting ERBB2 and Discovering ERBB3. Nature Reviews Cancer, 9, 463-475. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Saini, S.S. (2023) Urticaria and Basophils. Allergology International, 72, 369-374. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Varricchi, G., Galdiero, M.R., Loffredo, S., Marone, G., Iannone, R., Marone, G., et al. (2017) Are Mast Cells Masters in Cancer? Frontiers in Immunology, 8, Article 424. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Ben Dori, S., Aizic, A., Zubkov, A., Tsuriel, S., Sabo, E. and Hershkovitz, D. (2022) The Risk of PD-L1 Expression Misclassification in Triple-Negative Breast Cancer. Breast Cancer Research and Treatment, 194, 297-305. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Wherry, E.J. and Kurachi, M. (2015) Molecular and Cellular Insights into T Cell Exhaustion. Nature Reviews Immunology, 15, 486-499. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Fan, C., Tang, Y., Wang, J., Xiong, F., Guo, C., Wang, Y., et al. (2017) Role of Long Non-Coding Rnas in Glucose Metabolism in Cancer. Molecular Cancer, 16, Article No. 130. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Zhang, X., Luo, J. and Wu, L. (2022) FN1 Overexpression Is Correlated with Unfavorable Prognosis and Immune Infiltrates in Breast Cancer. Frontiers in Genetics, 13, Article 913659. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Calandra, T. and Roger, T. (2003) Macrophage Migration Inhibitory Factor: A Regulator of Innate Immunity. Nature Reviews Immunology, 3, 791-800. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Lee, H.N., Jeong, M.S. and Jang, S.B. (2021) Molecular Characteristics of Amyloid Precursor Protein (APP) and Its Effects in Cancer. International Journal of Molecular Sciences, 22, Article 4999. [Google Scholar] [CrossRef] [PubMed]
|